3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Smoking Cessation
2
Tobacco Use Disorder
1
Tobacco Smoking
1
Substance-Related Disorders
1
Neoplasms, Second Primary
1
Behavior, Addictive
1
Interventions
Temozolomide
2
Radiosurgery
2
Leucovorin
2
Irinotecan
2
Fluorouracil
2
sacubitril and valsartan sodium hydrate drug combination
1
icotinib
1
dostarlimab
1
beta Carotene
1
avelumab
1
alpha-Tocopherol
1
Varenicline
1
Tobacco Use Cessation Devices
1
Therapeutics
1
Thalidomide
1
Radiotherapy
1
Probiotics
1
Panitumumab
1
Nicotine Chewing Gum
1
Myofascial Release Therapy
1
Megestrol Acetate
1
Isotretinoin
1
Folfox protocol
1
Drug Therapy
1
Doxycycline
1
Docetaxel
1
Cryosurgery
1
Clonidine
1
Cetuximab
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neoplasms, Second Primary
×
Nicotine Chewing Gum
×
Clear all
NCT04634071
2026-02-02
TTOP
University of Kentucky
Phase 2
Completed
126 enrolled